Dr Eric Scott presents presents a case-based discussion on how advanced vascular imaging should guide the decision between an
Dr Ramon L. Varcoe presented an update on bioresorbable BTK technology, highlighting the growing body of evidence supporting
Alik Farber, MD, MBA, presented the latest 4-year findings from the landmark BEST-CLI trial. He challenged attendees to move
Yana Etkin, MD, presented an in-depth review of strategies for identifying and managing failing DVA, emphasizing that long
Drawing on current data and clinical experience, Luke R. Wilkins, MD, FSIR, highlights the importance of thoughtful patient selection and
Marianne Brodmann, MD, shares her insights on REALDES data and how they may impact the PAD field.
From redefining what “no-option” truly means, to understanding the role of small artery disease and medial arterial calcification in
Dr KJ Nagarsheth, Professor of Surgery, Division of Vascular Surgery, at the University of Maryland School of Medicine, offers a concise
Join a distinguished panel of vascular experts as they discuss the evolving landscape of endovascular therapy for BTK CLTI.
